-Dow Jones, citing Marke Talk
Morgan Stanley Maintains Equal-Weight on Elevance Health, Lowers Price Target to $485
Morgan Stanley analyst Ricky Goldwasser maintains Elevance Health (NYSE:ELV) with a Equal-Weight and lowers the price target from $533 to $485.